BIO-RAD LABORATORIES, INC. acquired Celsee, Inc. for $99.3 million total consideration, including fair value of contingent consideration of up to $60.0 million payable on certain 2021-2022 net-revenue achievement, a transaction completed in April 2020, structured as all cash plus contingent consideration.
Celsee, Inc. operates in Life Science. Celsee is a manufacturer of instruments and consumables for the isolation, detection, and analysis of single cells.
We believe this acquisition will complement our Life Science product offerings.
Single-cell isolation and analysis platform adjacent to Bio-Rad's Life Science franchise. Complements Life Science product offerings. Life Science segment
Celsee is a manufacturer of instruments and consumables for the isolation, detection, and analysis of single cells. We believe this acquisition will complement our Life Science product offerings.Bio-Rad Laboratories FY2020 10-K, Acquisitions note
Advisory firms were not disclosed for this transaction.